As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
|Articles|March 20, 2023
PAP 2023: Corey Ford Discusses Part D Requirements at Access PAP 2023
AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.
Advertisement
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Corey Ford, VP of reimbursement & insight policy, AmerisourceBergen, speaks on the Medicare Part D underinsured patient criteria (when it comes to patient assistance programs) and how it has evolved to more of an impact on patients' functionally uninsured criteria at Access PAP 2023.
Advertisement
Related to this article
Sponsored
Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
An FTC settlement moved one PBM aggregator onshore, but manufacturers still lack contract-level clarity on what affiliated fees actually buy.
Pharma pricing shifts beyond PBM rebates as Medicare and cash channels reshape launches, WAC cuts and access strategies.
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's five-year evolution and where serialized data is creating value beyond compliance.
HDA's Kala Shankle unpacks the biggest open question on preemption and offers a two-step playbook for wholesalers and 3PLs preparing for national licensure.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
White House Extends MFN Pricing to Every State Medicaid Program
2
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
3
How Rebate Timing Distorts a Pharmacy's 340B Books
4
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
5